BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28341718)

  • 1. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
    Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.
    Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA
    JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.
    Yassine HN; Feng Q; Azizkhanian I; Rawat V; Castor K; Fonteh AN; Harrington MG; Zheng L; Reed BR; DeCarli C; Jagust WJ; Chui HC
    JAMA Neurol; 2016 Oct; 73(10):1208-1216. PubMed ID: 27532692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits in non-demented diabetic elderly appear independent of brain amyloidosis.
    Chiang GC; Chang E; Pandya S; Kuceyeski A; Hu J; Isaacson R; Ganzer C; Schulman A; Sobel V; Vallabhajosula S; ; Ravdin L
    J Neurol Sci; 2017 Jan; 372():85-91. PubMed ID: 28017255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.
    Apostolova LG; Risacher SL; Duran T; Stage EC; Goukasian N; West JD; Do TM; Grotts J; Wilhalme H; Nho K; Phillips M; Elashoff D; Saykin AJ;
    JAMA Neurol; 2018 Mar; 75(3):328-341. PubMed ID: 29340569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC
    Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
    Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
    J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A
    Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
    Jack CR; Wiste HJ; Weigand SD; Rocca WA; Knopman DS; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Preboske GM; Pankratz VS; Vemuri P; Petersen RC
    Lancet Neurol; 2014 Oct; 13(10):997-1005. PubMed ID: 25201514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage.
    Asken BM; Elahi FM; La Joie R; Strom A; Staffaroni AM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Karydas A; Wang P; Rojas JC; Boxer AL; Miller BL; Rabinovici GD; Kramer JH; Casaletto KB
    J Alzheimers Dis; 2020; 78(1):265-276. PubMed ID: 32986672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
    Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
    JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Mielke MM; Vemuri P; Lowe V; Senjem ML; Gunter JL; Reyes D; Machulda MM; Roberts R; Petersen RC
    Brain; 2015 Dec; 138(Pt 12):3747-59. PubMed ID: 26428666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.